Lung adenocarcinoma patients of young age have lower EGFR mutation rate and poorer efficacy of EGFR tyrosine kinase inhibitors

Patients aged ≤50 years are rarely diagnosed with nonsmall cell lung cancer. We conducted a retrospective cohort study to understand the mutation status of EGFR and the efficacy of epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) treatment in young Asian patients with lung adeno...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Shang-Gin, Chang, Yih-Leong, Yu, Chong-Jen, Yang, Pan-Chyr, Shih, Jin-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507146/
https://www.ncbi.nlm.nih.gov/pubmed/28717642
http://dx.doi.org/10.1183/23120541.00092-2016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507146/
https://www.ncbi.nlm.nih.gov/pubmed/28717642
http://dx.doi.org/10.1183/23120541.00092-2016

Ejemplares similares